More Studies Show Positive Impacts From GLP-1 Agonist Drugs
A new survey from National Geographic explores many positive outcomes of recent trials with GLP-1 agonist drugs.
Drug Companies “Apathetic” About Testing GLP-1 Drugs to Treat Substance Use Disorders
Early studies of GLP-1 drugs for substance abuse treatment show promise, but drug companies are slow to fund research.
Liraglutide and Semaglutide Show Promise in the Treatment of Opioid Use Disorder and Alcohol Use Disorder
New research indicates that liraglutide, semaglutide, and similar GLP-1 drugs may be effective at reducing cravings for opioids and alcohol.
People Who Stop Taking GLP-1 Drugs Such As Ozempic and Wegovy Rapidly Gain Back Weight
New reporting documents the weight gain when people stop taking GLP-1 drugs such as Ozempic and Wegovy.
A Look at the Year Ahead From AddictionNews
A preview of the coming year, including everything from GLP-1 drugs to ibogaine to apps effective in the treatment of substance use disorders.
Is Ozempic Shrinking Profits for Snack Food Firms?
The snack food industry is bracing for reduced sales due to GLP-1 drugs such as Ozempic.